FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938034283> ?p ?o ?g. }

• W2938034283 abstract "The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing. The aim of the study was to provide reference survival data for patients with advanced iCCA treated with first-line cisplatin-gemcitabine chemotherapy (current standard of care). Individual data from patients with iCCA recruited into the prospective, random assignment Advanced Biliary Tract Cancer (ABC)-01, -02, and -03 studies were retrieved. The prevalence and survival of liver-only iCCA was also assessed. Survival analysis was performed using univariate and multivariable Cox regression. All statistical tests were two-sided. Of 534 patients recruited into the ABC-01, -02, and -03 studies, 109 (20.4%) had iCCA. Most patients (n = 86, 78.9%) had metastatic disease at the time of recruitment; 52 patients (47.7%) had liver-only disease. Following random assignment, 66 (60.6%) iCCA patients received cisplatin and gemcitabine. The median progression-free and overall survival (OS) were 8.4 months (95% confidence interval [CI] = 5.9 to 8.9 months) and 15.4 months (95% CI = 11.1 to 17.9 months), respectively. Of these 66 patients, 34 patients (51.5%) had liver-only disease. Following chemotherapy, 30 (45.5%) and 21 (31.8%) were progression-free at 3 and 6 months from chemotherapy commencement, respectively. The median OS for patients with liver-only iCCA at diagnosis and after 3 and 6 months of chemotherapy was 16.7 months (95% CI = 8.7 to 20.2 months), 17.9 months (95% CI = 11.7 to 20.9 months), and 18.9 months (95% CI = 16.7 to 25.9 months), respectively. Multivariable analysis confirmed that iCCA had a longer OS compared with other non-iCCA biliary tract cancers (hazard ratio = 0.58, 95% CI = 0.35 to 0.95, P value = .03); liver-only iCCA patients also showed longer OS even though findings did not reach statistical significance (hazard ratio = 0.65, 95% CI = 0.36 to 1.19, P value = .16). Patients diagnosed with advanced iCCA have a better OS compared with other biliary tract cancers; a similar trend was identified for patients diagnosed with liver-only iCCA. These findings are to be considered for future clinical trial design." @default.
• W2938034283 created "2019-04-25" @default.
• W2938034283 creator A5025272654 @default.
• W2938034283 creator A5027556665 @default.
• W2938034283 creator A5035078656 @default.
• W2938034283 creator A5041768679 @default.
• W2938034283 creator A5063738443 @default.
• W2938034283 creator A5075059160 @default.
• W2938034283 creator A5077826150 @default.
• W2938034283 creator A5083898918 @default.
• W2938034283 creator A5084034524 @default.
• W2938034283 creator A5087850177 @default.
• W2938034283 date "2019-05-11" @default.
• W2938034283 modified "2023-10-17" @default.
• W2938034283 title "Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials" @default.
• W2938034283 cites W1504363060 @default.
• W2938034283 cites W1651736482 @default.
• W2938034283 cites W1775323748 @default.
• W2938034283 cites W1970020295 @default.
• W2938034283 cites W1974564771 @default.
• W2938034283 cites W1975836447 @default.
• W2938034283 cites W1978614884 @default.
• W2938034283 cites W1984101482 @default.
• W2938034283 cites W1988476050 @default.
• W2938034283 cites W1997854400 @default.
• W2938034283 cites W1999642156 @default.
• W2938034283 cites W2000042204 @default.
• W2938034283 cites W2007555374 @default.
• W2938034283 cites W2015613033 @default.
• W2938034283 cites W2018040062 @default.
• W2938034283 cites W2018041848 @default.
• W2938034283 cites W2019607817 @default.
• W2938034283 cites W2025958291 @default.
• W2938034283 cites W2026656096 @default.
• W2938034283 cites W2027480170 @default.
• W2938034283 cites W2028028840 @default.
• W2938034283 cites W2034770797 @default.
• W2938034283 cites W2035964911 @default.
• W2938034283 cites W2052205828 @default.
• W2938034283 cites W2058269557 @default.
• W2938034283 cites W2058770031 @default.
• W2938034283 cites W2062328228 @default.
• W2938034283 cites W2071862424 @default.
• W2938034283 cites W2072564984 @default.
• W2938034283 cites W2073467830 @default.
• W2938034283 cites W2078797029 @default.
• W2938034283 cites W2087336559 @default.
• W2938034283 cites W2095101789 @default.
• W2938034283 cites W2095196969 @default.
• W2938034283 cites W2096888043 @default.
• W2938034283 cites W2106550415 @default.
• W2938034283 cites W2108756633 @default.
• W2938034283 cites W2112950772 @default.
• W2938034283 cites W2115261608 @default.
• W2938034283 cites W2117834374 @default.
• W2938034283 cites W2125804186 @default.
• W2938034283 cites W2134023012 @default.
• W2938034283 cites W2139248078 @default.
• W2938034283 cites W2141042450 @default.
• W2938034283 cites W2151660860 @default.
• W2938034283 cites W2155139924 @default.
• W2938034283 cites W2235523093 @default.
• W2938034283 cites W2344147562 @default.
• W2938034283 cites W2526881395 @default.
• W2938034283 cites W2539716675 @default.
• W2938034283 cites W2602621655 @default.
• W2938034283 cites W2630584086 @default.
• W2938034283 cites W2745824859 @default.
• W2938034283 cites W2809830289 @default.
• W2938034283 cites W2886807331 @default.
• W2938034283 cites W952389843 @default.
• W2938034283 doi "https://doi.org/10.1093/jnci/djz071" @default.
• W2938034283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31077311" @default.
• W2938034283 hasPublicationYear "2019" @default.
• W2938034283 type Work @default.
• W2938034283 sameAs 2938034283 @default.
• W2938034283 citedByCount "68" @default.
• W2938034283 countsByYear W29380342832018 @default.
• W2938034283 countsByYear W29380342832019 @default.
• W2938034283 countsByYear W29380342832020 @default.
• W2938034283 countsByYear W29380342832021 @default.
• W2938034283 countsByYear W29380342832022 @default.
• W2938034283 countsByYear W29380342832023 @default.
• W2938034283 crossrefType "journal-article" @default.
• W2938034283 hasAuthorship W2938034283A5025272654 @default.
• W2938034283 hasAuthorship W2938034283A5027556665 @default.
• W2938034283 hasAuthorship W2938034283A5035078656 @default.
• W2938034283 hasAuthorship W2938034283A5041768679 @default.
• W2938034283 hasAuthorship W2938034283A5063738443 @default.
• W2938034283 hasAuthorship W2938034283A5075059160 @default.
• W2938034283 hasAuthorship W2938034283A5077826150 @default.
• W2938034283 hasAuthorship W2938034283A5083898918 @default.
• W2938034283 hasAuthorship W2938034283A5084034524 @default.
• W2938034283 hasAuthorship W2938034283A5087850177 @default.
• W2938034283 hasBestOaLocation W29380342831 @default.
• W2938034283 hasConcept C120665830 @default.
• W2938034283 hasConcept C121332964 @default.
• W2938034283 hasConcept C126322002 @default.
• W2938034283 hasConcept C141071460 @default.
• W2938034283 hasConcept C144301174 @default.

• next